Clinical trials
Completed HIV Infections trials in India
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
47 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2002 | 3 |
| 2003 | 1 |
| 2004 | 2 |
| 2005 | 4 |
| 2006 | 5 |
| 2007 | 2 |
| 2008 | 3 |
| 2009 | 5 |
| 2010 | 2 |
| 2011 | 3 |
| 2012 | 2 |
| 2013 | 1 |
| 2014 | 1 |
| 2015 | 1 |
| 2016 | 2 |
| 2017 | 1 |
| 2018 | 1 |
| 2019 | 4 |
| 2021 | 2 |
| 2023 | 1 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Completed | 47 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| National Institute of Allergy and Infectious Diseases (NIAID) | 11 |
| Advancing Clinical Therapeutics Globally for HIV/AIDS and Other Infections | 7 |
| Johns Hopkins University | 4 |
| Kirby Institute | 2 |
| Singh, Ranjan Kumar, M.D. | 2 |
| University of California, Los Angeles | 2 |
| AIDS Malignancy Consortium | 1 |
| All India Institute of Medical Sciences | 1 |
| Brigham and Women's Hospital | 1 |
| Endo USA Inc., a Keenova Therapeutics Company | 1 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| HIV Infections | 47 |
| Acquired Immunodeficiency Syndrome | 8 |
| Tuberculosis | 7 |
| Sexually Transmitted Diseases | 3 |
| Tuberculosis, Pulmonary | 2 |
| Anorexia | 1 |
| Body Weight Changes | 1 |
| Cachexia | 1 |
| Candidiasis | 1 |
| Coinfection | 1 |
Trials
Showing 1 to 25 of 47. Each trial links to its page on Pharma Observatory.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
No changes to these trials in the last 7 days.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.